Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain
the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in
Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles
and JavaScript.
Nanomedicines are complex drugs where components that have typically been regarded as excipients may now be considered part of the active ingredient. The distinction between the active ingredient and excipients for nanomedicines has important consequences for regulatory review and product development. The dissimilarity in the review of the recent ribonucleic acid (RNA)-based lipid nanoparticles highlights the need for further regulatory alignment on this topic.
Recent advancements in DNA nanotechnology are enabling the construction of both aesthetically pleasing and functional structures using synthetic DNA strands, paving the way for practical applications in various fields.
Since the early 1990s, the intersection of genetics and nanomedicine has found a home in the clinic as one of the game changers of the past decade, holding great promise in fighting diseases by rapidly developing much-needed therapeutic platforms, from cancer to infectious or genetic diseases. And this revolution was just triggered by the amazing evolving world of messenger RNA and its ‘cues’.
Waste containing nanomaterials — or nanowaste — is an emerging safety concern worldwide, warranting specific environmentally sound waste management and regulation.
Let’s motor through the fog of molecular machine terminology, not only by defining our own words clearly, but by embracing the coexistence of multiple meanings in a rational and structured manner.
Perovskite quantum dots have been proven promising for photonic and optoelectronic applications, particularly, as bright and narrow band emitters for display technology. Despite the advantageous properties, the stability issues have to be resolved to unleash the full industrial potential of perovskite quantum dots in display technology.
Using our company’s CO2 electrolysers as a model, we describe the challenges involved in incorporating nanomaterial catalysts into industrial-scale electrolysers and suggest ways to more efficiently realize the performance improvements of academic-scale novel nanomaterials at industrial scales.
The recent advent of transition metal dichalcogenides moiré materials is a promising platform for studying correlated electron phenomena and moiré exciton physics.
The transition from a linear ‘take–make–dispose’ economy to a circular economy is gaining momentum. Although there are many opportunities for using nanotechnology to enable circularity, the knowledge gaps related to (eco-)toxicological hazards and the presence of nanomaterials in waste streams constitute significant challenges.
Nanoneedle start-ups are traversing the biotech valley of death — from fundamental university research into commercial development in advanced therapeutics and diagnostics. How can academics make the most of this opportunity?
We will now explicitly ask reviewers to flag up to us and authors whether a simpler model or theory could explain the experimental data in a given manuscript.
On a Thursday in March 2022, scientists from three continents gathered in Toulouse, France, to crown the best among eight international molecular racing teams competing in the second edition of the NanoCar Race.
Academic scientists who develop entrepreneurial capabilities can make strategic, path dependent decisions that enable university spin-offs to rapidly respond to global crises.
